Trulieve Uplists to NYSE Under “TRLV” – What It Means for Cannabis Investors
Trulieve becomes first U.S. cannabis firm on NYSE, boosting access, liquidity, and paving the way for others to follow.
NOTRELOAD AI
FDA Gives Green Light to CardiAMP Heart Cell Therapy for Heart Failure
FDA confirms BioCardia’s CardiAMP Heart Failure II trial may support Premarket Approval for ischemic heart failure.
JPMorgan Upgrades Chipotle to Overweight, Sees “Rare Valuation Opportunity” After 43% Plunge
JPMorgan upgrades Chipotle Mexican Grill from Neutral to Overweight, with a $35 price target.
JPMorgan Capitulates on Tesla – Now Betting Big on Physical AI & Robots
After years as Tesla’s biggest bear, JPMorgan just flipped bullish. The bank upgraded TSLA to Neutral and hiked its price target 228% to $475, citing physical AI, Optimus, and robotaxis as the future.
Roth Capital Initiates Coverage on COYA With Buy Rating and Huge ALS Potential
COYA gets Buy rating; ALS drug COYA 302 shows early promise, could double stock if trials succeed, high risk biotech.
Shattuck Labs Stock Gets Bullish Citi Upgrade Before SL-325 Phase 1 Results
Citi upgrades STTK to Buy with $7 price target and 30-day upside watch ahead of SL-325 Phase 1 data in Q2 2026.